B-12 is the AI copilot for chemistry that helps pharma companies create and test new molecules faster than ever. Acting like a GPS for drug discovery, the platform plans chemical recipes with precision and reduces early-stage discovery cycles from years to months. Backed by Y Combinator (S25) and led by world-class talent including Andres, who built the first autonomous molecule-making AI agent published in Nature Machine Intelligence (750+ citations, NeurIPS best paper winner), and Zlatko, a 3x Chemistry Olympiad champion and medicinal chemist with experience at Roche, B-12 has unmatched credibility. Their AI has already proven itself in paid pharma pilots, planning experiments that achieved full conversion on the first attempt and eliminating the usual 8 to 12 iteration loop. With a groundbreaking paper set to appear in Nature, B-12 is showing the world that molecular design can finally move at the speed of AI.

If your biotech startup needs a flyer that balances scientific depth with investor-ready clarity, book a call and we’ll design one that makes your research impossible to ignore.